Michael Thomas Ropacki

Michael Thomas Ropacki

Corporate Officer/Principal en ORYZON GENOMICS S.A. .

Health Technology
Consumer Services
Commercial Services

Perfil

Presently, Michael Thomas Ropacki is President of Strategic Global Research & Development.
He is also Chief Medical Officer-CNS at Oryzon Genomics SA. In his past career he was Head-Global Medical Affairs at Janssen Alzheimer Immunotherapy, Director-Clinical Development & Neuroscience at Janssen Research & Development LLC and Senior Vice President-Clinical Development at MedAvante-ProPhase, Inc. He received a doctorate from Texas Tech University.

Cargos activos de Michael Thomas Ropacki

EmpresasCargoInicio
ORYZON GENOMICS S.A. Corporate Officer/Principal 01/02/2021
Strategic Global Research & Development President -
Todos los cargos activos de Michael Thomas Ropacki

Antiguos cargos conocidos de Michael Thomas Ropacki.

EmpresasCargoFin
MedAvante-ProPhase, Inc. Chief Tech/Sci/R&D Officer 01/10/2017
Chief Tech/Sci/R&D Officer 01/02/2016
Janssen Alzheimer Immunotherapy Chief Tech/Sci/R&D Officer 01/05/2013
Ver el detalle de la experiencia de Michael Thomas Ropacki.

Formación de Michael Thomas Ropacki.

Texas Tech University Doctorate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Michael Thomas Ropacki.

Relaciones

24

Relaciones de 1er grado

6

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas1
ORYZON GENOMICS S.A.

Health Technology

Empresas privadas4
Janssen Alzheimer Immunotherapy

Commercial Services

MedAvante-ProPhase, Inc.

Strategic Global Research & Development

Ver las conexiones de la empresa
  1. Bolsa
  2. Insiders
  3. Michael Thomas Ropacki